| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | | Total Revenue | 168,954 | 819,393 | | Cost of Revenue | 54,325 | 39,750 | | | Gross Profit | 114,628 | 779,643 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 513 | 439 | | Non Recurring |
-
|
-
| | Others |
-
| 889 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 114,116 | 778,315 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,731,814) | (342,291) | | Earnings Before Interest And Taxes | 114,116 | 327,862 | | Interest Expense |
-
|
-
| | Income Before Tax | 114,116 | 327,862 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (1,617,698) | 436,024 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (1,617,698) | 436,024 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,617,698) | $436,024 |
|
0.15% Nasdaq 
Income Statement
